Type 1 diabetes

Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development

DiabetologiaPublished Prognostic modelling study

Authors' conclusion

CGM metrics can help predict disease progression and classify an individual's risk of type 1 diabetes diagnosis in conjunction with other factors. CGM can also be used to better assess the risk of type 1 diabetes progression and define eligibility for potential prevention trials.

Study context

Population
Participants with ≥1 positive islet AAb type from five studies: ASK, BDR, DAISY, DIPP and TrialNet Pathway to Prevention; baseline continuous glucose monitor (CGM) datafive studies · ASK 79 · BDR 22 · DAISY 18 · DIPP 8 · TrialNet Pathway to Prevention 91
Comparison
Full model vs characteristics-only model vs CGM-only model
Outcome
Prediction of stage 3 T1D diagnosis
Follow-up
Median 2.6 years (quartiles: 1.5 to 3.6 years)
Methodological detailspooled analysis of five studies, pooled data from five studies, model comparison
  • Pooled analysis of five studies
  • Pooled data from five studies
  • Model comparison

Performance

As reported in the abstract

Test or modelC statistic
Full model0.74 (95% CI 0.66, 0.81)
Characteristics-only model0.69 (95% CI 0.60, 0.77)
CGM-only model0.68 (95% CI 0.61, 0.75)

C statistic

Full model0.74 (95% CI 0.66, 0.81)
Characteristics-only model0.69 (95% CI 0.60, 0.77)
CGM-only model0.68 (95% CI 0.61, 0.75)

Further findings

Probability of symptomatic disease by full-model risk class · 2 years

Factors associated with greater risk of T1D diagnosis

Greater % time >7.8 mmol/l
P < 0.001
HbA1c
P = 0.02
First-degree relative with T1D
P = 0.02
Positive IA-2 AAb
P < 0.001
Male sex (selected, not significant)
P = 0.06
Negative GAD AAb (selected, not significant)
P = 0.09

Original publication

Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development. Diabetologia. Published 11 February 2025. doi:10.1007/s00125-025-06362-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.